Chinese Center for Disease Control and Prevention, Beijing 102206, China;Capital Institute of Pediatrics, Beijing 100020, China.
Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Biomed Environ Sci. 2022 Jan 20;35(1):13-21. doi: 10.3967/bes2022.003.
This study aims to investigate the association of metabolic phenotypes that are jointly determined by body mass index (BMI) or fat mass percentage and metabolic health status with the ten-year risk of cardiovascular disease (CVD) among Chinese adults.
Data were obtained from a cross-sectional study. BMI and body fat mass percentage (FMP) combined with the metabolic status were used to define metabolic phenotypes. Multiple linear regression and logistic regression were used to examine the effects of metabolic phenotypes on CVD risk.
A total of 13,239 adults aged 34-75 years were included in this study. Compared with the metabolically healthy non-obese (MHNO) phenotype, the metabolically unhealthy non-obese (MUNO) and metabolically unhealthy obese (MUO) phenotypes defined by BMI showed a higher CVD risk [odds ratio, (95% confidence interval, ): 2.34 (1.89-2.89), 3.45 (2.50-4.75), respectively], after adjusting for the covariates. The MUNO and MUO phenotypes defined by FMP showed a higher CVD risk [ (95% ): 2.31 (1.85-2.88), 2.63 (1.98-3.48), respectively] than the MHNO phenotype. The metabolically healthy obese phenotype, regardless of being defined by BMI or FMP, showed no CVD risk compared with the MHNO phenotype.
General obesity without central obesity does not increase CVD risk in metabolically healthy individuals. FMP might be a more meaningful factor for the evaluation of the association of obesity with CVD risk. Obesity and metabolic status have a synergistic effect on CVD risk.
本研究旨在探讨联合由体重指数(BMI)或体脂百分比和代谢健康状况决定的代谢表型,与中国成年人 CVD(心血管疾病)十年发病风险之间的关系。
数据来源于一项横断面研究。采用 BMI 和体脂肪百分比(FMP)结合代谢状态来定义代谢表型。采用多元线性回归和逻辑回归来检验代谢表型对 CVD 风险的影响。
本研究共纳入 13239 名年龄 34-75 岁的成年人。与代谢健康非肥胖(MHNO)表型相比,BMI 定义的代谢不健康非肥胖(MUNO)和代谢不健康肥胖(MUO)表型的 CVD 风险更高[比值比(95%置信区间):2.34(1.89-2.89),3.45(2.50-4.75)],调整混杂因素后。FMP 定义的 MUNO 和 MUO 表型的 CVD 风险更高[比值比(95%:2.31(1.85-2.88),2.63(1.98-3.48)],与 MHNO 表型相比。无论 BMI 还是 FMP 定义的代谢健康肥胖表型,与 MHNO 表型相比,均无 CVD 风险。
代谢健康的单纯性肥胖不增加中心性肥胖个体的 CVD 风险。FMP 可能是评估肥胖与 CVD 风险相关性的更有意义的因素。肥胖和代谢状态对 CVD 风险具有协同作用。